Sunshine Biopharma Inc (SBFM)
0.3796
-0.18
(-31.96%)
USD |
NASDAQ |
Jun 10, 16:00
0.3805
0.00 (0.00%)
After-Hours: 20:00
Sunshine Biopharma Max Drawdown (5Y): 100.00% for May 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
May 31, 2024 | 100.00% |
April 30, 2024 | 100.00% |
March 31, 2024 | 100.00% |
February 29, 2024 | 100.00% |
January 31, 2024 | 100.00% |
December 31, 2023 | 100.00% |
November 30, 2023 | 100.00% |
October 31, 2023 | 100.00% |
September 30, 2023 | 100.00% |
August 31, 2023 | 100.00% |
July 31, 2023 | 100.00% |
June 30, 2023 | 100.00% |
May 31, 2023 | 100.00% |
April 30, 2023 | 100.00% |
March 31, 2023 | 100.00% |
February 28, 2023 | 100.00% |
January 31, 2023 | 100.00% |
December 31, 2022 | 100.00% |
November 30, 2022 | 100.00% |
October 31, 2022 | 100.00% |
September 30, 2022 | 100.00% |
August 31, 2022 | 100.00% |
July 31, 2022 | 100.00% |
June 30, 2022 | 100.00% |
May 31, 2022 | 100.00% |
Date | Value |
---|---|
April 30, 2022 | 100.00% |
March 31, 2022 | 100.00% |
February 28, 2022 | 100.00% |
January 31, 2022 | 99.99% |
December 31, 2021 | 99.99% |
November 30, 2021 | 99.99% |
October 31, 2021 | 99.99% |
September 30, 2021 | 99.99% |
August 31, 2021 | 99.99% |
July 31, 2021 | 99.99% |
June 30, 2021 | 99.99% |
May 31, 2021 | 99.99% |
April 30, 2021 | 99.99% |
March 31, 2021 | 99.99% |
February 28, 2021 | 99.99% |
January 31, 2021 | 99.99% |
December 31, 2020 | 99.99% |
November 30, 2020 | 99.99% |
October 31, 2020 | 99.99% |
September 30, 2020 | 99.99% |
August 31, 2020 | 99.99% |
July 31, 2020 | 99.99% |
June 30, 2020 | 99.99% |
May 31, 2020 | 99.99% |
April 30, 2020 | 99.99% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.83%
Minimum
Jun 2019
100.00%
Maximum
Feb 2022
99.98%
Average
99.99%
Median
May 2020
Max Drawdown (5Y) Benchmarks
Lexaria Bioscience Corp | 98.90% |
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Xenon Pharmaceuticals Inc | 64.74% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -68.45 |
Beta (5Y) | -1.097 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 941.6% |
Historical Sharpe Ratio (5Y) | -0.0887 |
Historical Sortino (5Y) | -1.110 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 67.99% |